Further, a series of gene profiling studies [21]–[26] showed that TLX is overexpressed in various types of human glioma, including neuroblastoma, astrocytoma, and ependymona, and its expression was correlated with a poor prognosis. Here, NR2E1 is linked to central nervous system cancer.